Raul Rodriguez
Chief Executive Officer chez RIGEL PHARMACEUTICALS, INC.
Fortune : 3 M $ au 31/03/2024
Profil
Raul R.
Rodriguez is currently the President, Chief Executive Officer & Director at Rigel Pharmaceuticals, Inc. He previously worked as the Executive Director-Business Development at Scios, Inc. from 1994 to 1997, and as the Senior VP-Business Development & Operations at Ontogeny, Inc. from 1997 to 2000.
Mr. Rodriguez holds a graduate degree from the University of Illinois, an MBA from Stanford Graduate School of Business, and an undergraduate degree from Harvard College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 28/02/2024 | 2 036 629 ( 1,16% ) | 3 M $ | 31/03/2024 |
Postes actifs de Raul Rodriguez
| Sociétés | Poste | Début |
|---|---|---|
| RIGEL PHARMACEUTICALS, INC. | Chief Executive Officer | 21/11/2014 |
Anciens postes connus de Raul Rodriguez
| Sociétés | Poste | Fin |
|---|---|---|
Ontogeny, Inc.
 Ontogeny, Inc. BiotechnologyHealth Technology Ontogeny, Inc., located in Cambridge, Massachusetts whose mission is to become the preeminent biopharmaceutical company focused on translating developmental biology insights into regenerative medicine therapies that will significantly improve the quality of life by activating the body's ability to repair and regenerate, or to specifically control abnormal and malignant growth. The Company is developing therapeutics for neurological diseases including Parkinson's and Alzheimer's diseases, diabetes and dermatological disorders including skin cancer and hair growth. | Chief Operating Officer | 01/03/2000 |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Corporate Officer/Principal | 01/03/1997 |
Formation de Raul Rodriguez
| University of Illinois | Graduate Degree |
| Stanford Graduate School of Business | Masters Business Admin |
| Harvard College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| RIGEL PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Health Technology |
Ontogeny, Inc.
Ontogeny, Inc. BiotechnologyHealth Technology Ontogeny, Inc., located in Cambridge, Massachusetts whose mission is to become the preeminent biopharmaceutical company focused on translating developmental biology insights into regenerative medicine therapies that will significantly improve the quality of life by activating the body's ability to repair and regenerate, or to specifically control abnormal and malignant growth. The Company is developing therapeutics for neurological diseases including Parkinson's and Alzheimer's diseases, diabetes and dermatological disorders including skin cancer and hair growth. | Health Technology |
